LAVA Therapeutics Files Definitive Proxy Statement
| Field | Detail |
|---|---|
| Company | Lava Therapeutics NV |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, governance
TL;DR
LAVA Therapeutics filed its proxy statement, shareholders vote soon.
AI Summary
LAVA Therapeutics N.V. filed a Definitive Proxy Statement (DEF 14A) on April 28, 2025, for the fiscal year ending December 31, 2025. The filing concerns the company's proxy materials, which are typically used for shareholder meetings to vote on corporate matters. The company is incorporated in P7 and its principal executive offices are located in Utrecht, Netherlands.
Why It Matters
This filing provides shareholders with essential information regarding upcoming votes and corporate governance, allowing them to make informed decisions about the company's direction.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- LAVA Therapeutics N.V. (company) — Registrant
- 0001104659-25-040196.txt (document) — Filing document identifier
- 20250428 (date) — Filing date
- 20250611 (date) — Period of report
- 0001840748 (company_id) — Central Index Key
- 2834 (industry_code) — Standard Industrial Classification
- Yalelaan 62, Utrecht, P7 3584 CM (address) — Business and mail address
- 31 6 3000 3035 (phone_number) — Business phone number
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is filed by a company to provide shareholders with information they need to vote on matters at a shareholder meeting.
When was this DEF 14A filed by LAVA Therapeutics N.V.?
This DEF 14A was filed on April 28, 2025.
What is the reporting period for this filing?
The conformed period of report for this filing is June 11, 2025.
Where are LAVA Therapeutics N.V.'s principal executive offices located?
LAVA Therapeutics N.V.'s principal executive offices are located at Yalelaan 62, Utrecht, P7 3584 CM.
What is LAVA Therapeutics N.V.'s Standard Industrial Classification code?
LAVA Therapeutics N.V.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding LAVA Therapeutics NV.